MedPath
FDA Approval

PROGESTERONE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Actavis Pharma, Inc.
DUNS: 119723554
Effective Date
October 5, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Progesterone(50 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PROGESTERONE

Product Details

NDC Product Code
0591-3128
Application Number
NDA017362
Marketing Category
NDA (C73594)
Route of Administration
INTRAMUSCULAR
Effective Date
October 5, 2022
Code: 4G7DS2Q64YClass: ACTIBQuantity: 50 mg in 1 mL
BENZYL ALCOHOLInactive
Code: LKG8494WBHClass: IACT
SESAME OILInactive
Code: QX10HYY4QVClass: IACT
© Copyright 2025. All Rights Reserved by MedPath